Additional effects of Bcl-2 inhibitors on cancer cells beyond their role in triggering apoptosis have been demonstrated, including the induction of cell cycle arrest, the inhibition of cell proliferation and the induction of autophagy and necrotic cell death [20, 38, 39]. Here, BCL2 is linked to cancer.